dpp-4 inhibitor with glp-1 receptor agonist combination not recommended ada Clinical Focus on Agonists in Type 2 Diabetes Mellitus GLP 1 Receptor Agonists and

Recent multi-omics studies have revealed that patients with CFS/ME, especially in early disease stages, display pronounced disruptions in both gut microbial composition and metabolic profiles (Wang J.-H

Catalpol inhibits the proliferation, migration and metastasis of HCC cells by regulating miR-140-5p expression

[186] Mesolimbic dopamine neurons co-express the glutamate transporter EAAT3 alongside DAT, permitting amphetamine-induced EAAT3 internalization to influence glutamatergic signaling in the mesolimbic pathway

New England Journal of Medicine , 337 (9), 581-588

Apoptosis, oncosis, and necrosis

Bolesatine, a toxic protein from the mushroom Rubroboletus satanas